How and where to order Bimatoprost (Latisse, Lumigan, Careprost) ophthalmic solution 0.03% 3 ml online:
LATISSE (BIMATOPROST) OPHTHALMIC SOLUTION 0.03%: PRECAUTIONS (see "References")
Hair Growth Outside the Treatment Area
There is the potential for hair growth to occur in areas where Bimatoprost (Latisse) solution comes in repeated contact with the skin surface. It is important to apply Latisse only to the skin of the upper eyelid margin at the base of the eyelashes using the accompanying sterile applicators, and to carefully blot any excess Bimatoprost (Latisse) ophthalmic solution from the eyelid margin to avoid it running onto the cheek or other skin areas.
Intraocular Inflammation
Latisse solution should be used with caution in patients with active intraocular inflammation (e.g., uveitis) because the inflammation may be exacerbated.
Macular Edema
Macular edema, including cystoid macular edema, has been reported during treatment with bimatoprost ophthalmic solution (Lumigan) for elevated IOP. Bimatoprost (Latisse) eye drops should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.
Contamination of Latisse or Applicators
The Latisse bottle must be kept intact during use. It is important to use Bimatoprost (Latisse) ophthalmic solution 0.03% as instructed, by placing one drop on the single-use-per eye applicator. The bottle tip should not be allowed to contact any other surface since it could become contaminated. The accompanying sterile applicators should only be used on one eye and then discarded since reuse of applicators increases the potential for contamination and infections. There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
Use with Contact Lenses
Latisse contains benzalkonium chloride, which may be absorbed by soft contact lenses. Contact lenses should be removed prior to application of solution and may be reinserted 15 minutes following its administration.
Recent posts:
Latisse prescribing information
|